Improving gut health through diet and mindfulness may reduce gut inflammation and the risk of chronic disease. Find out which ...

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Psoriasis is a chronic, inflammatory skin condition, of which there are several types. Knowing what type of psoriasis you have can help you and your doctor come up with an effective treatment plan ...

New research links ultra-processed food intake to higher psoriasis risk, even after accounting for genetics, BMI, and lifestyle, highlighting the potential of dietary changes in preventing chronic ...

But no matter which hair removal process you use, there is another factor to consider if you have psoriasis: how the method may impact your skin and whether it may trigger a flare. “One of the ...

Such infections are initiated at mucosal surfaces, where there is a close association between polarized epithelial cells and immune effector cells. However, vaccines are usually given ...

Natasha Nettles is a strong woman. She’s a mom, a makeup artist, and she also happens to have psoriasis. But she doesn’t let this one part of her life take her down. She doesn’t let it ...

Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.

Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings ...

Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam ...